Gold prices scale record highs as investors seek safe haven

Spot gold has reached a historic milestone, surpassing $4,000 for the first time, reflecting a significant 50% increase this year, driven by central bank purchases and ongoing political instability. This surge in gold prices is noteworthy as it indicates a growing trend among investors seeking safe-haven assets amid economic uncertainty. Meanwhile, Vertu Motors has reported a £5.5 million profit hit due to disruptions from Jaguar Land Rover, highlighting challenges in the automotive sector. The retirement of Peter Hargreaves, co-founder of Hargreaves Lansdown, adds another layer of change in the investment landscape.

Spot gold has reached a historic milestone, surpassing $4,000 for the first time, reflecting a significant 50% increase this year, driven by central bank purchases and ongoing political instability. This surge in gold prices is noteworthy as it indicates a growing trend among investors seeking safe-haven assets amid economic uncertainty. Meanwhile, Vertu Motors has reported a £5.5 million profit hit due to disruptions from Jaguar Land Rover, highlighting challenges in the automotive sector. The retirement of Peter Hargreaves, co-founder of Hargreaves Lansdown, adds another layer of change in the investment landscape.

Spot gold has reached a historic milestone, surpassing $4,000 for the first time, reflecting a significant 50% increase this year, driven by central bank purchases and ongoing political instability. This surge in gold prices is noteworthy as it indicates a growing trend among investors seeking safe-haven assets amid economic uncertainty. Meanwhile, Vertu Motors has reported a £5.5 million profit hit due to disruptions from Jaguar Land Rover, highlighting challenges in the automotive sector. The retirement of Peter Hargreaves, co-founder of Hargreaves Lansdown, adds another layer of change in the investment landscape.

Jefferies has resumed coverage on Rentokil's stock with a Buy rating, highlighting strong momentum in the US market. This is significant as it reflects confidence in Rentokil's growth potential and could attract more investors, boosting the company's stock performance.

Jefferies has resumed coverage on Rentokil's stock with a Buy rating, highlighting strong momentum in the US market. This is significant as it reflects confidence in Rentokil's growth potential and could attract more investors, boosting the company's stock performance.

Gold prices have surged past $4,000 an ounce, marking a significant milestone as investors flock to this safe-haven asset amid rising debt concerns and challenges facing the US dollar. This shift not only highlights the growing appeal of gold but also raises questions about the future stability of dollar-denominated assets like Treasury Bonds. The Trump administration's uncertainty regarding furloughed workers' pay adds to the economic anxiety, making gold's rise even more relevant as a protective investment.

Gold prices have surged past $4,000 an ounce, marking a significant milestone as investors flock to this safe-haven asset amid rising debt concerns and challenges facing the US dollar. This shift not only highlights the growing appeal of gold but also raises questions about the future stability of dollar-denominated assets like Treasury Bonds. The Trump administration's uncertainty regarding furloughed workers' pay adds to the economic anxiety, making gold's rise even more relevant as a protective investment.

Gold prices have surged past $4,000 an ounce, marking a significant milestone as investors flock to this safe-haven asset amid rising debt concerns and challenges facing the US dollar. This shift not only highlights the growing appeal of gold but also raises questions about the future stability of dollar-denominated assets like Treasury Bonds. The Trump administration's uncertainty regarding furloughed workers' pay adds to the economic anxiety, making gold's rise even more relevant as a protective investment.

Thailand's central bank has decided to hold interest rates steady, a move that surprised many analysts. While the bank has trimmed its GDP growth forecast, it has also indicated that it remains open to further rate cuts if necessary. This decision is significant as it reflects the bank's cautious approach to managing economic growth amidst global uncertainties, and it could influence investor confidence and spending in the region.

In September, Hungary's consumer prices remained unchanged, keeping the inflation rate steady at 4.3%. This stability in prices is significant as it reflects the country's economic resilience amidst global economic fluctuations. Maintaining a consistent inflation rate can help consumers and businesses plan better, fostering a more predictable economic environment.

In Japan, a new leader is pushing for the central bank to take measures that would make government debt more manageable, similar to recent moves in the U.S. This approach could potentially lead to increased inflation, raising concerns about economic stability. Understanding these developments is crucial as they may influence monetary policy and economic conditions in both countries.

Recent alternative job data from Wall Street indicates that the U.S. labor market is losing momentum, with many companies showing reluctance to hire. This trend is concerning as it suggests a potential slowdown in economic growth, impacting not just job seekers but also overall consumer confidence and spending.

Mizuho has lowered its stock price target for Shift4 Payments due to international headwinds affecting the company's performance. This adjustment reflects concerns about the challenges Shift4 may face in global markets, which could impact its growth and profitability. Investors should pay attention to these developments as they could influence the stock's future trajectory.

RBC Capital has raised its price target for Select Medical's stock to $20, citing recent regulatory relief as a key factor. This adjustment reflects growing confidence in the company's future performance and highlights the positive impact of regulatory changes on its operations. Investors may see this as a promising sign for Select Medical's growth potential.

Mizuho has lowered its price target for Corteva's stock to $78 following the company's announcement of a stock split. This adjustment reflects concerns about the potential impact of the split on investor confidence and market performance. Investors should pay attention to how this change might affect Corteva's stock in the coming months, as it could influence trading strategies and overall market sentiment.

Zenas Biopharma has successfully licensed three promising autoimmune candidates from InnoCare, marking a significant step forward in their development pipeline. This collaboration not only enhances Zenas's portfolio but also underscores the growing importance of innovative treatments in the autoimmune space. The partnership is expected to accelerate research and bring new therapies to patients in need, highlighting the potential for improved health outcomes.

Frontline stock has received a reaffirmed 'Buy' rating from BTIG, reflecting confidence in the company's performance amid a robust tanker market. This endorsement is significant as it highlights the potential for growth and profitability in the shipping sector, which is currently benefiting from increased demand and favorable market conditions.

In a remarkable achievement, Yoshio Kitagawa, David Robson, and Omar Yaghi have been awarded the 2025 Nobel Prize in Chemistry for their groundbreaking work in the field of porous materials. This recognition not only highlights their innovative contributions but also underscores the importance of chemistry in addressing global challenges such as energy storage and environmental sustainability. Their research paves the way for future advancements that could significantly impact various industries and improve our daily lives.